Terug
26
Dagbereik
€ 83,77
€ 86,47
52-Weeksbereik
€ 62,00
€ 127,56
Volume
344.345
50D / 200D Gem.
€ 85,43
/
€ 94,09
Vorige Slotkoers
€ 85,33
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 29,4 | 0,3 |
| P/B | 1,7 | 2,9 |
| ROE % | 6,1 | 3,7 |
| Net Margin % | 5,6 | 3,8 |
| Rev Growth 5Y % | 11,0 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 102,75
+19.2%
Low: € 82,00
High: € 133,00
Forward K/W
13,2
Forward WPA
€ 6,49
WPA Groei (sch.)
+0,0%
Omzet Sch.
1,8 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2029 |
€ 8,64
€ 8,50 – € 8,71
|
2,2 B | 4 |
| FY2028 |
€ 7,88
€ 7,76 – € 7,95
|
2,1 B | 3 |
| FY2027 |
€ 7,23
€ 7,02 – € 7,36
|
2 B | 6 |
Belangrijkste Punten
Revenue grew 11,00% annually over 5 years — strong growth
Earnings declined -14,25% over the past year
Generating 105,12M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3,02%
Cash machine — converts 102,24% of earnings into free cash flow
Capital efficient — spends only 4,91% of revenue on capex
Groei
Revenue Growth (5Y)
11,00%
Revenue (1Y)7,98%
Earnings (1Y)-14,25%
FCF Growth (3Y)32,06%
Kwaliteit
Return on Equity
6,11%
ROIC5,71%
Net Margin5,55%
Op. Margin12,93%
Veiligheid
Debt / Equity
0,80
Current Ratio3,32
Interest Coverage5,55
Waardering
P/E Ratio
29,37
P/B Ratio1,73
EV/EBITDA18,37
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 7,98% | Revenue Growth (3Y) | 9,16% |
| Earnings Growth (1Y) | -14,25% | Earnings Growth (3Y) | 6,50% |
| Revenue Growth (5Y) | 11,00% | Earnings Growth (5Y) | 1,51% |
| Profitability | |||
| Revenue (TTM) | 1,85B | Net Income (TTM) | 102,81M |
| ROE | 6,11% | ROA | 3,01% |
| Gross Margin | 26,99% | Operating Margin | 12,93% |
| Net Margin | 5,55% | Free Cash Flow (TTM) | 105,12M |
| ROIC | 5,71% | FCF Growth (3Y) | 32,06% |
| Safety | |||
| Debt / Equity | 0,80 | Current Ratio | 3,32 |
| Interest Coverage | 5,55 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 29,37 | P/B Ratio | 1,73 |
| P/S Ratio | 1,63 | PEG Ratio | -1,49 |
| EV/EBITDA | 18,37 | Dividend Yield | 0,00% |
| Market Cap | 3,02B | Enterprise Value | 4,40B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,85B | 1,72B | 1,56B | 1,33B | 1,22B |
| Net Income | 102,81M | 119,90M | 90,65M | 66,38M | 96,81M |
| EPS (Diluted) | 2,89 | 3,40 | 2,69 | 1,96 | 2,80 |
| Gross Profit | 500,39M | 461,18M | 411,52M | 346,65M | 336,97M |
| Operating Income | 239,62M | 208,24M | 163,32M | 112,68M | 135,71M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,41B | 3,08B | 2,94B | 2,79B | 2,58B |
| Total Liabilities | 1,66B | 1,46B | 1,42B | 1,38B | 1,23B |
| Shareholders' Equity | 1,75B | 1,62B | 1,52B | 1,42B | 1,35B |
| Total Debt | 1,40B | 1,10B | 1,05B | 1,01B | 905,81M |
| Cash & Equivalents | 17,16M | 46,54M | 23,67M | 24,27M | 17,89M |
| Current Assets | 770,10M | 671,12M | 617,67M | 558,30M | 452,98M |
| Current Liabilities | 232,04M | 227,17M | 220,97M | 223,75M | 159,63M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#905 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026